HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Metabolism and Cancer: Novel Therapeutic Targets

Metabolism and Cancer: Novel Therapeutic Targets

Targeting cancer metabolism has emerged as a promising therapeutic approach, particularly in the context of novel drug discovery. Metabolic alterations in cancer cells support their growth, survival, and resistance to treatment. Researchers are investigating how metabolic pathways, such as those involved in glucose uptake, fatty acid oxidation, and amino acid metabolism, can be modulated to disrupt cancer cell function. Targeting metabolic enzymes or signaling pathways could sensitize tumors to chemotherapy, immunotherapy, or radiation, potentially overcoming resistance mechanisms. By identifying specific metabolic vulnerabilities in cancer cells, researchers hope to design more effective and less toxic therapies that selectively target the altered metabolism of cancer cells, offering hope for patients with hard-to-treat cancers.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Ahora Chehri

Ahora Chehri

Johann Wolfgang Goethe Universität Frankfurt am, Germany
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Ratan Kumar Sarkar

Ratan Kumar Sarkar

Independent Researcher, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp
Metabolism and Cancer: Novel Therapeutic Targets | Cancer